Nuvigil a sister Drug Of Provigil is supposed to be approved in the third quarter of this year.
Cephalon which owns Provigil and nuvigil.Cephalon Inc.’s stock closed up 9 percent at $5.87 per share Tuesday, after the company announced positive results from a phase-II study of Nuvigil, which was developed as a sleep disorder drug, in patients with bipolar depression .The company’s stock closed at $69.06. Anyone heard what the big difference is going to be from Provigil? I know Provigil made me kind of jittery: I am praying this Nuvigil will help with my depression and ADHD symptoms.
Please Comment.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment